Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)
CNY 10.57
(-1.03%)
CNY 10.57
(-1.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 35.69 Million | 144.64 Million | -12.53 Million | -4.5 Million | 320.14 Million | 292.45 Million |
| Net Income | 70.07 Million | 26.5 Million | 349.67 Million | 26.63 Million | 173.86 Million | 204.38 Million |
| Depreciation & Amortization | 108.67 Million | 106.56 Million | 99.13 Million | 79.94 Million | 78.99 Million | 73.8 Million |
| Deferred income taxes | 8.64 Million | 11.69 Million | 95.01 Million | -1.44 Million | 7.2 Million | 4.67 Million |
| Stock-based compensation | 18.69 Million | 8.14 Million | - | - | - | - |
| Change in working capital | -96.32 Million | 49.48 Million | 107.42 Million | -160.09 Million | 76.11 Million | 41.61 Million |
| Other non-cash items | 10.37 Million | -37.91 Million | -568.76 Million | 49.01 Million | -8.82 Million | -27.35 Million |
| Investing Cash Flow | -260.52 Million | 419.25 Million | -278.23 Million | 201.29 Million | -127.97 Million | -160.46 Million |
| Investments in PPE | -299.57 Million | -89.22 Million | -73.94 Million | -145.85 Million | -198.63 Million | -78.41 Million |
| Acquisitions | -15.97 Million | 270.33 Thousand | 11.61 Million | 146.43 Million | 199.37 Million | - |
| Investment purchases | -60.43 Million | -72 Million | -1.11 Billion | -1.09 Billion | -2.27 Billion | -2.48 Billion |
| Sales/Maturities of investments | 115.24 Million | 580.2 Million | 901.88 Million | 1.43 Billion | 2.34 Billion | 2.39 Billion |
| Other Investing Activities | 55.03 Million | 0.26 | -4.05 Million | -145.85 Million | -198.63 Million | 557.46 Thousand |
| Financing Cash Flow | -15.08 Million | -107.12 Million | -43.7 Million | -2.55 Million | -178.09 Million | -27.61 Million |
| Debt repayment | -44.82 Million | -270.21 Million | -269.53 Million | -230 Million | -58 Million | -30 Million |
| Dividends payments | -31.63 Million | -99.13 Million | -24.78 Million | -86.73 Million | -202.53 Million | -107.45 Million |
| Common Stock Repurchased | -1.16 Million | - | - | - | -85.77 Million | - |
| Common Stock Issuance | - | 47.29 Million | - | - | 85.77 Million | - |
| Other Financing Activities | -18.87 Million | 272.42 Million | 260.14 Million | 323.23 Million | 88.93 Million | 109.84 Million |
| Accounts receivables | -6.74 Million | -10.02 Million | 49.6 Million | 49.08 Million | -59 Million | -67.26 Million |
| Accounts payables | -51.42 Million | 47.19 Million | -63.69 Million | -239.61 Million | 161.55 Million | 143.24 Million |
| Inventory | -46.8 Million | 622.96 Thousand | 26.48 Million | 31.87 Million | -33.63 Million | -39.04 Million |
| Other working capital | -42.77 Million | 11.69 Million | 95.01 Million | -1.44 Million | 7.2 Million | 80.65 Million |
| Cash at beginning of period | 782.26 Million | 325.49 Million | 659.97 Million | 465.74 Million | 451.67 Million | 347.29 Million |
| Cash at end of period | 542.35 Million | 782.26 Million | 325.49 Million | 659.97 Million | 465.74 Million | 451.67 Million |
| Capital Expenditure | -299.57 Million | -89.22 Million | -73.94 Million | -145.85 Million | -198.63 Million | -78.41 Million |
| Effect of forex changes on cash | - | - | - | 0.69 | 0.62 | - |
| Net cash flow / Change in cash | -239.91 Million | 456.77 Million | -334.47 Million | 194.22 Million | 14.06 Million | 104.37 Million |
| Free Cash Flow | -263.88 Million | 55.41 Million | -86.48 Million | -150.36 Million | 121.5 Million | 214.04 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.31 Million | 7.48 Million | 18.78 Million | 70.07 Million | 13.53 Million | 7.93 Million |
| Depreciation & Amortization | - | 28.7 Million | 28.7 Million | 108.67 Million | 108.67 Million | -53.43 Million |
| Deferred income taxes | - | - | - | 8.64 Million | - | 57.06 Million |
| Stock-based compensation | - | 5.12 Million | - | 18.69 Million | 18.69 Million | -11.66 Million |
| Change in working capital | - | -92.72 Million | - | -96.32 Million | -53.54 Million | 8.02 Million |
| Other non-cash items | 4.59 Million | 13.72 Million | -54.55 Million | 10.37 Million | -60.35 Million | -19.05 Million |
| Investing Cash Flow | -38.86 Million | -163.38 Million | -95.55 Million | -260.52 Million | -64.53 Million | -121.77 Million |
| Investments in PPE | -75.02 Million | -117.39 Million | -65.56 Million | -299.57 Million | -93.89 Million | -87.08 Million |
| Acquisitions | 17.02 Thousand | 382.00 | 2236.00 | -15.97 Million | -15.97 Million | 15.16 Thousand |
| Investment purchases | -60.07 Million | -141 Million | -30 Million | -60.43 Million | 15.14 Million | -55.57 Million |
| Sales/Maturities of investments | 96.21 Million | 110 Million | - | 115.24 Million | 30.18 Million | 20.87 Million |
| Other Investing Activities | 17.02 Thousand | -15 Million | -29.99 Million | 55.03 Million | 45.33 Million | 1.12 |
| Financing Cash Flow | -1.29 Million | 101.79 Million | 204.45 Million | -15.08 Million | 2.82 Million | -6.7 Million |
| Debt repayment | -13.77 Million | -10.69 Million | -204.93 Million | -44.82 Million | -41 Thousand | -9.97 Million |
| Dividends payments | -5.84 Million | -88.32 Million | -3.44 Million | -31.63 Million | -31.63 Million | -2.36 Million |
| Common Stock Repurchased | - | - | - | -1.16 Million | -1.16 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.22 Million | 114.27 Million | -471.74 Thousand | -18.87 Million | 5.28 Million | 5.63 Million |
| Accounts receivables | - | -45.41 Million | - | -6.74 Million | -6.74 Million | -4.32 Million |
| Accounts payables | - | - | - | -51.42 Million | - | - |
| Inventory | - | -47.31 Million | - | -46.8 Million | -46.8 Million | 12.35 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 546.4 Million | 1.06 Billion | 1.04 Billion | 782.26 Million | 595.75 Million | 736.21 Million |
| Cash at end of period | 523.93 Million | 776.1 Million | 1.06 Billion | 542.35 Million | 542.35 Million | 595.75 Million |
| Capital Expenditure | -75.02 Million | -117.39 Million | -65.56 Million | -299.57 Million | -93.89 Million | -87.08 Million |
| Effect of forex changes on cash | - | - | - | - | - | -871.96 Thousand |
| Net cash flow / Change in cash | -22.47 Million | -289.31 Million | 17.95 Million | -239.91 Million | -53.39 Million | -140.46 Million |
| Free Cash Flow | -56.11 Million | -124.89 Million | -101.32 Million | -263.88 Million | -85.57 Million | -98.19 Million |
HAG
STI
BZYR
1860
TISCY
BSM